TCM
PTHS

Tradewinds Capital Management’s Pelthos Therapeutics PTHS Stock Holding History

Tradewinds Capital Management’s Portfolio PTHS Stock Details PTHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-20
Closed -$284 – 702
2025
Q1 		$284 Buy
+20
New +$342 ﹤0.01% 613

Other funds holding PTHS

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Tradewinds Capital Management's PTHS Position: Q2 2025 in Review

Tradewinds Capital Management sold out of Pelthos Therapeutics (PTHS) in Q2 2025, closing a stake of 20 shares — an estimated $284 sold.

Tradewinds Capital Management first reported a position in PTHS in Q1 2025 and held it in 1 quarter. The position peaked at $284 in Q1 2025. 5 funds tracked by Wall St. Rank hold PTHS as of Q2 2025.

  • Tradewinds Capital Management reported no remaining Pelthos Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Tradewinds Capital Management sold 20 Pelthos Therapeutics shares in Q2 2025, an estimated $284.
  • Tradewinds Capital Management first reported a position in Pelthos Therapeutics in Q1 2025 and held it in 1 quarter.
  • Tradewinds Capital Management's Pelthos Therapeutics position peaked at $284 in Q1 2025.
  • 5 funds tracked by Wall St. Rank held Pelthos Therapeutics as of Q2 2025.

Based on Tradewinds Capital Management's 13F filing for Q2 2025, filed 29 Jul 2025.